drugset / Trial / NCT03441581
Eluxadoline Bile Acid Malabsorption (BAM) Study
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study will evaluate the possibility of a differential effect of eluxadoline on altered bowel function in Irritable Bowel Syndrome with Diarrhea (IBS-D) participants with and without evidence of Bile Acid Malabsorption (BAM).
Timeline
- Start
- 2018-02-23
- Primary completion
- 2020-04-28
- Completion
- 2020-04-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eluxadoline | Small molecule | 100 mg | Oral |